The effect of PEG-coated gold nanoparticles on the anti-proliferative potential of Specific Nutrient Synergy

Nanotoxicology

Volumn 4, Issue 2, 2010, Pages 177-185

  Harakeh, Steve ^a   Abdel Massih, Roula M ^b   Gil, Pilar Rivera ^c   Sperling, Ralph A ^c   Meinhardt, Andreas ^d   Niedwiecki, Aleksandra ^a   Rath, Matthias ^a   Parak, Wolfgang J ^c   Baydoun, Elias ^e  

^a Dr Rath Research Institute   (United States)

^b UNIVERSITY OF BALAMAND   (Lebanon)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Drug delivery; Nano surfaces; Nanomedicine; Nanoparticles; Nanoscience

Indexed keywords

ANTIOXIDANT; GOLD NANOPARTICLE; MACROGOL; SPECIFIC NUTRIENT SYNERGY; UNCLASSIFIED DRUG;

ARTICLE; CELL DENSITY; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; INTERNALIZATION; LEUKEMIA CELL LINE; MOLECULAR WEIGHT; PRIORITY JOURNAL; T LYMPHOCYTE;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DIETARY SUPPLEMENTS; DRUG SYNERGISM; GOLD; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; POLYETHYLENE GLYCOLS; T-LYMPHOCYTES;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 77952809213     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390903569621     Document Type: Article

References (43)

1. Akerman ME, Chan WCW, et al. 2002. Nanocrystal targeting in vivo. Proc Nat Acad Sci USA 99(20):12617-12621.
2. Ballou B, Lagerholm BC, et al. 2004. Noninvasive imaging of quantum dots in mice. Bioconjugate Chem 15(1):79-86.
3. Bentzen EL, Tomlinson ID, et al. 2005. Surface modification to reduce nonspecific binding of quantum dots in live cell assays. Bioconjugate Chem 16(6):1488-1494.
4. Brennan JL, Hatzakis NS, et al. 2006. Bionanoconjugation via click chemistry: The creation of functional hybrids of lipases and gold nanoparticles. Bioconjugate Chem 17(6): 1373-1375.
5. Burda C, Chen X, et al. 2005. Chemistry and properties of nanocrystals of different shapes. Chem Rev 105(4): 1025-1102.
6. Chang E, Thekkek N, et al. 2006. Evaluation of quantum dot cytotoxicity based on intracellular uptake. Small 2(12): 1412-1417.
7. Cuenca AG, Jiang HB, et al. 2006. Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer 107(3):459-466.
8. Daniel MC, Astruc D. 2004. Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 104(1):293-346.
9. Daou TJ, Li L, et al. 2009. Effect of poly(ethylene glycol) length on the in vivo behavior of coated quantum dots. Langmuir 25(5):3040-3044.
10. De-la-Fuente JM, Penades S. 2006. Glyconanoparticles: Types, synthesis and applications in glycoscience, biomedicine and material science. Biochim Biophys Acta 1760(4):636-651.
11. Delehanty J,Mattoussi H, et al. 2009. Delivering quantum dots into cells: Strategies, progress and remaining issues. Analyt Bioanalytical Chem 393(4):1091-1105.
12. Dixit SK, Goicochea NL, et al. 2006. Quantum dot encapsulation in viral capsids. Nano Lett 6(9):1993-1999.
13. Foley GE, Lazarus H, et al. 1965. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18(4):522-529.
14. Gao X, Cui Y, et al. 2004. In vivo cancer targeting and imaging with semiconductor quantum dots. Nature Biotechnol 22(8): 969-976.
15. Green TR, Fisher J, et al. 1998. Polyethylene particles of a 'critical size' are necessary for the induction of cytokines by macrophages in vitro. Biomaterials 19(24):2297-2302.
16. Gupta AK, Curtis ASG. 2004. Surface modified superparamagnetic nanoparticles for drug delivery: Interaction studies with human fibroblasts in culture. J Materials Sci -Materials Med 15(4):493-496.
17. Harakeh S, Diab-Assaf M, et al. 2006. Mechanistic aspects of apoptosis induction by L-lysine in both HTLV-1-positive and -negative cell lines. Chem-Biolog Interact 164(1-2): 102-114.
18. Harakeh S, Diab-Assef M, et al. 2004. Inhibition of proliferation and induction of apoptosis by 2-benzoyl-3-phenyl-6,-7-dichloroquinoxaline 1,4-dioxide in adult T-cell leukemia cells. Chem-Biolog Interact 148(3):101-113.
19. Jiang W, Kim BYS, et al. 2008. Nanoparticle-mediated cellular response is size-dependent. Nat Nano 3(3):145.
20. Jiang X, Weise S, Hafner M, Röcker C, Zhang F, Parak WJ, Nienhaus GU. 2010. Quantitative analysis of the protein corona on FePt nanoparticles formed by transferrin binding. J R Soc Interface 7:S5-S13.
21. Lin C-AJ, Sperling RA, et al. 2008. Design of an amphiphilic polymer for nanoparticle coating and functionalization. Small 4(3):334-341.
22. Lorenz MR, Holzapfel V, et al. 2006. Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. Biomaterials 27(14):2820-2828.
23. Mao ZW, Wang B, et al. 2007. The influence of polycaprolactone coating on the internalization and cytotoxicity of gold nanoparticles. Nanomed - Nanotechnol Biol Med 3(3): 215-223.
24. Masala O, Seshadri R. 2004. Synthesis routes for large volumes of nanoparticles. Annu Rev Materials Res 34:41-81.
25. McNeil SE. 2005. Nanotechnology for the biologist. J Leukoc Biol 78(3):585-594.
26. Murray CB, Kagan CR, et al. 2000. Synthesis and characterization of monodisperse nanocrystals and close-packed nanocrystals assemblies. Annu Rev Mater Sci. 30:545-610.
27. Nativo P, Prior IA, et al. 2008. Uptake and intracellular fate of surface-modified gold nanoparticles. ACS Nano 1639-1644.
28. Paciotti GF, Myer L, et al. 2004. Colloidal gold: A novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 11(3):169-183.
29. Pellegrino T, Manna L, et al. 2004. Hydrophobic nanocrystals coated with an amphiphilic polymer shell: A general route to water soluble nanocrystals. Nanoletters 4(4):703-707.
30. Perez-Juste J, Pastoriza-Santos I, et al. 2005. Gold nanorods: Synthesis, characterization and applications. Coordin Chem Rev 249:1870-1901.
31. Pissuwan D, Valenzuela SM, et al. 2006. Therapeutic possibilities of plasmonically heated gold nanoparticles. Trends Biotechnol 24(2):62-67.
32. Rivera-Gil P, Parak WJ. 2008. Composite nanoparticles take aim at cancer. ACS Nano 2(11):2200-2205.
33. Röcker C, Pötzl M, et al. 2009. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nature Nanotechnol 4(9):577-580.
34. Sperling RA, Liedl T, et al. 2007. Size determination of (bio-) conjugated water-soluble colloidal nanoparticles - a comparison of different techniques. J Phys Chem C 111(31): 11552-11559.
35. Sperling RA, Pellegrino T, et al. 2006. Electrophoretic separation of nanoparticles with a discrete number of functional groups. Adv Funct Materials 16(7):943-948.
36. Sperling RA, Rivera-Gil P, et al. 2008. Biological applications of gold nanoparticles. Chem Soc Rev 37(9):1896-1908.
37. Susumu K, Uyeda HT, et al. 2007. Enhancing the stability and biological functionalities of quantum dots via compact multifunctional ligands. J Am Chem Soc 129(45): 13987-13996.
38. Templeton AC, Wuelfing WP, et al. 2000. Monolayerprotected cluster molecules. Acc Chem Res 33(1):27-36.
39. Thevenot P, Cho J, et al. 2008. Surface chemistry influences cancer killing effect of TiO2 nanoparticles. Nanomed - Nanotechnol Biol Med 4(3):226-236.
40. Van-Vlerken L, Vyas T, et al. 2007. Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharmaceut Res 24(8):1405.
41. Wattendorf U, Kreft O, et al. 2008. Stable stealth function for hollow polyelectrolyte microcapsules through a poly (ethylene glycol) grafted polyelectrolyte adlayer. Biomacromolecules 9(1):100-108.
42. Zhang LW, Yu WW, et al. 2008. Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicol Appl Pharmacol 228(2): 200-211.
43. Zhang Y, Kohler N, et al. 2002. Surface modification of superparamagnetic magnetic nanoparticles and their intracellular uptake. Biomaterials 23:1553-1561.